Journal of Crohns & Colitis

Scope & Guideline

Unraveling complexities of gastrointestinal health.

Introduction

Welcome to the Journal of Crohns & Colitis information hub, where our guidelines provide a wealth of knowledge about the journal’s focus and academic contributions. This page includes an extensive look at the aims and scope of Journal of Crohns & Colitis, highlighting trending and emerging areas of study. We also examine declining topics to offer insight into academic interest shifts. Our curated list of highly cited topics and recent publications is part of our effort to guide scholars, using these guidelines to stay ahead in their research endeavors.
LanguageEnglish
ISSN1873-9946
PublisherOXFORD UNIV PRESS
Support Open AccessNo
CountryUnited Kingdom
TypeJournal
Convergefrom 2007 to 2024
AbbreviationJ CROHNS COLITIS / J. Crohns Colitis
Frequency12 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
AddressGREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND

Aims and Scopes

The Journal of Crohns & Colitis aims to advance the understanding and management of inflammatory bowel diseases (IBD), particularly Crohn's disease and ulcerative colitis. The journal serves as a platform for disseminating high-quality research that spans clinical, translational, and basic science relevant to IBD.
  1. Clinical Research and Trials:
    The journal publishes findings from clinical trials and observational studies that explore the efficacy and safety of various treatment modalities, including biologics and small molecules.
  2. Pathophysiology and Disease Mechanisms:
    Research focusing on the underlying mechanisms of IBD, including genetic, immunological, and microbiological factors that contribute to disease onset and progression.
  3. Diagnostic Innovations:
    Studies on new diagnostic tools, such as imaging techniques and biomarkers, aimed at improving early detection and disease monitoring.
  4. Nutritional and Dietary Interventions:
    Exploration of how dietary patterns and nutritional interventions influence disease activity and patient outcomes in IBD.
  5. Quality of Life and Patient-Centered Care:
    Research addressing the psychosocial aspects of IBD, including quality of life, mental health, and the impact of the disease on daily living.
  6. Epidemiology and Health Services Research:
    Studies that investigate the epidemiology of IBD, healthcare utilization, and disparities in access to treatment.
Recent publications in the Journal of Crohns & Colitis reflect emerging trends and themes that highlight the evolving landscape of research in inflammatory bowel disease. These areas are gaining traction and are likely to shape future studies.
  1. Microbiome Research:
    There is a notable increase in studies exploring the gut microbiota's role in IBD pathogenesis, treatment response, and disease management, indicating a shift towards personalized medicine approaches.
  2. Biologic and Small Molecule Therapies:
    Research on newer biologics and JAK inhibitors is on the rise, reflecting their growing importance in treatment protocols for IBD, particularly in refractory cases.
  3. Digital Health and Telemedicine:
    The integration of digital health tools and telemedicine in managing IBD has gained momentum, especially in light of the COVID-19 pandemic, highlighting patient-centered approaches to care.
  4. Real-World Evidence Studies:
    An increasing number of publications are focused on real-world data and observational studies to assess the effectiveness and safety of treatments in diverse patient populations.
  5. Patient-Reported Outcomes and Quality of Life:
    There is a growing emphasis on understanding the patient's perspective, including the impact of IBD on quality of life and mental health, as well as the importance of shared decision-making in treatment.

Declining or Waning

While the Journal of Crohns & Colitis has consistently focused on advancing research in various aspects of inflammatory bowel disease, certain themes appear to be declining in prominence based on recent publications.
  1. Traditional Pharmacotherapy:
    Research on older pharmacological treatments, such as 5-aminosalicylic acids and thiopurines, has decreased in frequency, likely due to the increasing focus on biologics and novel therapies.
  2. Surgical Approaches:
    While surgical management remains important, the volume of studies solely focused on surgical techniques without integration into broader treatment paradigms has diminished, as there is a shift towards understanding IBD as a chronic disease needing multidisciplinary management.
  3. Animal Models of IBD:
    The reliance on animal models for studying IBD mechanisms may be waning as there is a growing emphasis on human-derived data and translational research that directly informs clinical practice.

Similar Journals

JOURNAL OF GASTROENTEROLOGY

Leading the way in gastroenterology research excellence.
Publisher: SPRINGER JAPAN KKISSN: 0944-1174Frequency: 12 issues/year

JOURNAL OF GASTROENTEROLOGY, published by SPRINGER JAPAN KK, is a premier academic journal that has been at the forefront of gastrointestinal research since its inception in 1994. With an impressive Impact Factor and ranking in the top quartile (Q1) of its category, this journal holds a significant place in the field of gastroenterology, currently ranked 12th out of 167 in Scopus, placing it in the 93rd percentile. The journal serves as an essential platform for disseminating innovative research, clinical studies, and reviews that foster advancements in the understanding and treatment of gastrointestinal diseases. Although it does not offer Open Access options, it provides researchers, clinicians, and students access to crucial insights and breakthroughs pivotal to improving patient care and outcomes in gastroenterology. With a commitment to high-quality peer-reviewed content, JOURNAL OF GASTROENTEROLOGY plays a vital role in shaping the future of gastrointestinal health and research.

Nature Reviews Gastroenterology & Hepatology

Exploring Breakthroughs in Liver and Digestive Disorders
Publisher: NATURE PORTFOLIOISSN: 1759-5045Frequency: 12 issues/year

Nature Reviews Gastroenterology & Hepatology is a premier academic journal published by NATURE PORTFOLIO, specializing in the vital fields of gastroenterology and hepatology. With an impressive impact factor and categorized in Q1 for both disciplines, this journal ranks at the top of its field, with Scopus rankings placing it in the 99th percentile for gastroenterology and hepatology. The journal aims to provide critical reviews that synthesize the latest research findings, clinical practices, and breakthroughs, catering to researchers, healthcare professionals, and students alike. With its wide-ranging access options, it promotes the dissemination of knowledge essential for advancements in understanding digestive and liver disorders. The journal has been committed to academic excellence since its convergence in 2009, continuing to shape the future of gastroenterological and hepatological research through rigorous peer-reviewed content.

WORLD JOURNAL OF GASTROENTEROLOGY

Elevating research in gastrointestinal medicine.
Publisher: BAISHIDENG PUBLISHING GROUP INCISSN: 1007-9327Frequency: 48 issues/year

WORLD JOURNAL OF GASTROENTEROLOGY, published by BAISHIDENG PUBLISHING GROUP INC, stands at the forefront of gastrointestinal research, providing a critical platform for the dissemination of high-quality studies in the field. With an impressive impact factor reflected in its Q1 rankings in both Gastroenterology and Miscellaneous Medicine, this journal is recognized for its rigorous peer-review process and commitment to advancing knowledge and practices related to digestive health. Covering comprehensive scopes from clinical advancements to innovative therapies, the journal serves an essential role for researchers, clinicians, and students, enabling them to stay updated on the latest developments and findings from 1998 through 2024. The open access model facilitates broader accessibility, ensuring that groundbreaking research reaches a global audience. The journal's ranking within the top 15% of Scopus demonstrates its significant contribution to the academic community, making it a valuable resource for advancing the science of gastroenterology.

Gastrointestinal Disorders

Pioneering Research for a Healthier Digestive Future
Publisher: MDPIISSN: Frequency: 4 issues/year

Gastrointestinal Disorders is a prominent open-access journal published by MDPI, based in Switzerland, that focuses on the latest research and innovations in the fields of gastroenterology, hepatology, and immunology. Since its inception in 2019, the journal has provided a vital platform for researchers and professionals to disseminate their findings, engaging with a global audience keen on advancing knowledge in gastrointestinal health. With a dedicated commitment to high-quality, peer-reviewed articles, Gastrointestinal Disorders has gained recognition in 2023, achieving Q3 status in gastroenterology and notable rankings in several other categories, including a respectable position in the quartiles for hepatology, immunology, and oncology. Despite its recent establishment, the journal has quickly become a valuable resource, facilitating open access to critical insights in the study of gastrointestinal diseases and their management, ensuring that emerging research is readily available to inform clinical practice and educate future professionals.

DIGESTION

Connecting researchers with groundbreaking discoveries in digestion.
Publisher: KARGERISSN: 0012-2823Frequency: 6 issues/year

DIGESTION is a prestigious journal dedicated to advancing the field of gastroenterology, published by KARGER, a renowned publisher based in Switzerland. With a rich history dating back to 1896, this journal has continuously evolved and serves as a vital platform for researchers, professionals, and students alike. DIGESTION is recognized for its scholarly contributions, holding an impressive rank of 23 out of 167 in the Scopus database, placing it within the top 14% of gastroenterology journals, as evidenced by its Q2 classification. The journal's commitment to high-quality research is reflected in its wide-ranging scope, addressing various aspects of digestive health, clinical practices, and innovative therapies. Though not an open-access journal, it provides comprehensive access options that ensure the dissemination of crucial research findings to the global community. As we move towards 2024, DIGESTION continues to facilitate dialogue and insights in gastroenterological research, making it an indispensable resource for those in the field.

Translational Gastroenterology and Hepatology

Leading the Charge in Translational Medicine for Digestive Health.
Publisher: AME PUBLISHING COMPANYISSN: Frequency: 4 issues/year

Translational Gastroenterology and Hepatology, published by AME Publishing Company, stands as a pivotal platform for advancing the understanding and treatment of gastrointestinal and liver diseases. With its focus on translational research, this journal aims to bridge the gap between laboratory discoveries and clinical applications, thus fostering improvements in patient care. Although specific metrics like H-Index and Scopus ranks are currently unavailable, the journal is committed to maintaining high standards of scholarly communication and excellence. As an open-access publication, it ensures that valuable findings are readily accessible to a global audience, promoting collaboration and innovation among researchers, clinicians, and healthcare professionals invested in gastroenterology and hepatology. The journal's dedication to disseminating groundbreaking research makes it an essential resource for those seeking to stay at the forefront of these ever-evolving fields.

INFLAMMATORY BOWEL DISEASES

Leading the way in inflammatory bowel disease research.
Publisher: OXFORD UNIV PRESS INCISSN: 1078-0998Frequency: 12 issues/year

INFLAMMATORY BOWEL DISEASES is a premier journal published by Oxford University Press, Inc., dedicated to advancing research within the fields of gastroenterology and immunology. With an impressive impact factor reflecting its status as a Q1 category journal in both gastroenterology and immunology and allergy, it ranks 17th out of 167 in gastroenterology and 53rd out of 233 in immunology, underscoring its influence and authority within the scientific community. Since its inception in 1995 and continuing through to 2024, the journal has become an essential resource for researchers, healthcare professionals, and students, serving as a platform for the latest findings in the diagnosis, treatment, and management of inflammatory bowel diseases. While the journal operates under a subscription-based model, it is recognized for its rigorous peer-review process and commitment to publishing high-caliber, impactful studies that contribute significantly to understanding and treating these complex conditions.

Frontline Gastroenterology

Elevating Knowledge in Gastroenterology and Hepatology
Publisher: BMJ PUBLISHING GROUPISSN: 2041-4137Frequency: 4 issues/year

Frontline Gastroenterology is a leading academic journal published by the BMJ Publishing Group that plays a vital role in advancing the field of gastroenterology and hepatology. Established in 2013, this prestigious journal has established itself as a significant resource for researchers, healthcare professionals, and students alike, maintaining a commendable impact factor and consistently achieving a Q2 ranking in both gastroenterology and hepatology categories as of 2023. With its focus on disseminating high-quality, peer-reviewed research, Frontline Gastroenterology covers a wide scope of topics pertinent to the understanding, diagnosis, and treatment of gastrointestinal and liver diseases. Although it does not offer Open Access options, its content is accessible through various institutional and personal subscriptions, ensuring that critical findings reach an international audience. As the journal continues to converge into the future, it remains dedicated to fostering innovation and dialogue in gastroenterological sciences.

SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY

Illuminating the Complexities of Gastrointestinal Diseases
Publisher: TAYLOR & FRANCIS LTDISSN: 0036-5521Frequency: 12 issues/year

SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, published by Taylor & Francis Ltd, is a leading journal in the field of gastroenterology, dedicated to advancing clinical and experimental research related to digestive health. With an ISSN of 0036-5521 and an E-ISSN of 1502-7708, this journal provides a platform for high-quality research that addresses the complexities of gastrointestinal diseases. Since its inception in 1966, the journal has consistently contributed valuable insights and is currently categorized in the Q2 quartile of gastroenterology journals, reflecting its impact and relevance in the field, with a Scopus rank of 87 out of 167 in Medicine - Gastroenterology. Researchers and practitioners are encouraged to explore the journal's archives to enhance their understanding and stay abreast of innovative strategies for managing gastrointestinal disorders. The SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY remains a crucial resource for those committed to improving patient outcomes through rigorous scientific inquiry and the sharing of impactful findings.

Clinical Gastroenterology and Hepatology

Exploring Breakthroughs in Liver and Gastrointestinal Research
Publisher: ELSEVIER SCIENCE INCISSN: 1542-3565Frequency: 12 issues/year

Clinical Gastroenterology and Hepatology, published by Elsevier Science Inc, stands as a leading journal in the fields of gastroenterology and hepatology. With an ISSN of 1542-3565 and an E-ISSN of 1542-7714, this esteemed publication has earned its place in the top quartile (Q1) of both gastroenterology and hepatology categories as of 2023, ranking 6th out of 167 and 7th out of 82 respectively. The journal aims to disseminate innovative research, clinical studies, and case reports that advance the understanding and treatment of gastrointestinal and liver diseases. Targeted towards researchers, healthcare professionals, and students, it provides crucial insights into emerging therapies and medical advancements. Clinical Gastroenterology and Hepatology is not only a pivotal resource for contemporary gastroenterological research but also fosters collaboration and knowledge-sharing within the medical community. With a converging publication history from 2003 to the present, the journal continues to build on its solid foundation of scientific excellence and relevance.